GSTT1
Evidence of association of glutathione-S-transferase GSTT1 and GSTM1 null genotypes with susceptibility to oral cancer based on meta-analysis
Association study between GSTM1 and GSTT1 genotypes and other possible risk factors in prostate cancer patients in a population from southwest Bahia, Brazil
GSTT1 null genotype in sickle cell anemia and blood transfusion recurrence – a case report
Polymorphisms of the genes eNOS, GSTT1 and GSTM1 are significantly associated with atherosclerotic disease in hypertensive patients
Null polymorphisms in GSTT1 and GSTM1 genes and their associations with smoking and cervical cancer
Association of glutathione S-transferase (GST) genetic polymorphisms with treatment outcome of cisplatin-based chemotherapy for advanced non-small cell lung cancer in a Chinese population
The aim of this study was to evaluate the association of GSTM1 null/present, GSTT1 null/present, and GSTP1 IIe105Val polymorphisms with the chemotherapy response and overall survival of advanced NSCLC. Two hundred and sixty-two patients with histologically confirmed advanced NSCLC (inoperable TNM stages IIIA, IIIB, and IV) were enrolled to this hospital-based study between May 2009 and May 2012.
Glutathione S-transferase polymorphisms in varicocele patients: a meta-analysis
The glutathione S-transferase (GST) family represents a major group of detoxification and antioxidant enzymes. Studies have shown that high oxidative stress levels are associated with varicocele. The objective of this study was to assess the relationship between GSTM1 and GSTT1 null polymorphisms and varicocele using a study group of 497 varicocele patients and 476 control subjects. A systematic literature search (for articles published up to September 2014) utilizing Google Scholar and PubMed was conducted.